9 Aug 2017 - 10 Aug 2017
Boston, MA, USA
Our Kymab team is delighted to be part of the Canaccord Genuity 37th Annual Growth Conference
Kymab, a leading biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs, uses its proprietary Kymouse antibody platform for internal drug discovery programmes and in partnership with pharmaceutical companies.
We will be part of the Canaccord Genuity 37th Annual Growth Conference, held August 9-10, 2017, at the InterContinental Boston Hotel in Boston, MA.